Background: Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy,
responsible for 13 000 deaths per year in the United States. Risk prediction based on …

Background Few biomarkers of ovarian cancer prognosis have been established, partly
because subtype-specific associations might be obscured in studies combining all …

… Bowtell, Kathryn Alsop, Mine S. Cicek, Julie M. Cunningham, Brooke L. Fridley, Jennifer
Alsop, Mercedes Jimenez-Linan, Estrid Høgdall, Claus K. Høgdall, Allan Jensen, Susanne …

Importance Cytotoxic CD8 + tumor-infiltrating lymphocytes (TILs) participate in immune control
of epithelial ovarian cancer; however, little is known about prognostic patterns of CD8 + …

The aim of this study was to estimate the contribution of deleterious mutations in BRCA1,
BRCA2, MLH1, MSH2, MSH6 and PMS2 to invasive epithelial ovarian cancer (EOC) in the …

We aimed to validate the prognostic association of p16 expression in ovarian high‐grade
serous carcinomas (HGSC) and to explore it in other ovarian carcinoma histotypes. p16 protein …

Primary ovarian mucinous tumors can be difficult to distinguish from metastatic gastrointestinal
neoplasms by histology alone. The expected immunoprofile of a suspected metastatic …

Purpose: Gene expression–based molecular subtypes of high-grade serous tubo-ovarian
cancer (HGSOC), demonstrated across multiple studies, may provide improved stratification …

Our objective was to test whether p53 expression status is associated with survival for
women diagnosed with the most common ovarian carcinoma histotypes (high‐grade serous …

Background There is evidence that some ovarian tumours evoke an immune response, which
can be assessed by tumour infiltrating lymphocytes (TILs). To facilitate adoption of TILs as …